🟢 Omada Health is trading 5% up today after record revenue and higher 2026 guidance

Omada Health is trading 5% up at $24.86 after investors continued responding to the August 6 earnings report, which delivered record $88 million revenue, profitability, and raised 2026 revenue guidance to $334 million–$340 million.

• Adjusted EBITDA guidance increased to $21 million–$27 million.
• Management announced a January 1, 2027 CEO transition.
• The broader market is slightly weaker, suggesting company-specific earnings momentum is driving the gain.